Dudediligence.

Annexon, Inc

ANNXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$34.8MSep ’24−$48.6MDec ’24−$54.4MMar ’25−$49.2MJun ’25−$54.9MSep ’25−$48.3MDec ’25−$44.1MMar ’26−$55.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$130.7M−$145.6M−$143.7M−$154.1M−$216.4M
Net income−$130.3M−$141.9M−$134.2M−$138.2M−$206.7M
Operating cash flow−$106.1M−$116.3M−$121.1M−$118.0M−$186.4M
Free cash flow−$107.8M−$122.8M−$121.3M−$118.0M−$186.5M
Cash$74.8M$140.0M$225.1M$49.5M$162.1M
Shares outstanding38.6M47.7M78.4M109.4M149.4M